Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNM | ZTS | TAK | UTHR | NBIX |
| Company | Actinium Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1000 | 169.65 | 15.10 | 313.93 | 112.36 |
| High | 1.1300 | 177.00 | 15.18 | 323.99 | 113.87 |
| Low | 1.0900 | 169.64 | 15.01 | 313.93 | 110.78 |
| Last | 1.1200 | 171.80 | 15.04 | 317.87 | 110.87 |
| Change | -0.0200 | +1.43 | -0.13 | +1.96 | -2.17 |
| % Change | -1.75% | +0.84% | -0.86% | +0.62% | -1.92% |
| Volume | 119,000 | 3,183,900 | 2,275,900 | 436,000 | 1,273,100 |
| 20-Day Average Volume | 154,480 | 4,087,635 | 1,492,250 | 610,950 | 1,520,025 |
| Previous Close | 1.1400 | 170.37 | 15.17 | 315.91 | 113.04 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1400 | 166.07 | 14.22 | 342.11 | 115.83 |
| 20-Day Raw Stochastic | 35.52% | 77.07% | 91.15% | 16.39% | 3.95% |
| 20-Day Relative Strength | 45.25% | 54.60% | 69.75% | 37.34% | 32.60% |
| Weighted Alpha | -65.78 | -1.15 | +9.36 | +19.30 | -24.81 |
| Today's Opinion | 100% Sell | 64% Sell | 40% Buy | 72% Sell | 56% Sell |
| Previous Opinion | 96% Sell | 64% Sell | 40% Buy | 72% Sell | 56% Sell |
| Last Month's Opinion | 100% Sell | 40% Sell | 40% Sell | 8% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.66% since 03/03/25 | +0.74% since 03/03/25 | +1.35% since 03/03/25 | +2.53% since 03/03/25 | -3.15% since 03/03/25 |
| Low | 1.0292 on 03/04/25 | 165.22 on 03/05/25 | 14.81 on 03/04/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 1.1600 on 03/05/25 | 177.00 on 03/10/25 | 15.22 on 03/07/25 | 323.99 on 03/10/25 | 115.31 on 03/06/25 |
| 1-Month | |||||
| %Chg | -0.88% since 02/10/25 | -0.06% since 02/10/25 | +11.99% since 02/10/25 | -8.03% since 02/10/25 | -6.68% since 02/10/25 |
| Low | 1.0292 on 03/04/25 | 154.32 on 02/18/25 | 13.19 on 02/12/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 1.2848 on 02/19/25 | 177.00 on 03/10/25 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 122.37 on 02/21/25 |
| 3-Month | |||||
| %Chg | -13.85% since 12/10/24 | -2.78% since 12/10/24 | +11.74% since 12/10/24 | -12.25% since 12/10/24 | -14.03% since 12/10/24 |
| Low | 1.0292 on 03/04/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 1.4800 on 01/06/25 | 181.85 on 12/13/24 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 154.61 on 01/30/25 |
| 6-Month | |||||
| %Chg | -40.43% since 09/10/24 | -10.22% since 09/10/24 | +1.01% since 09/10/24 | -7.18% since 09/10/24 | -6.91% since 09/10/24 |
| Low | 1.0292 on 03/04/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 2.0100 on 09/13/24 | 200.33 on 09/19/24 | 15.22 on 03/07/25 | 417.82 on 11/08/24 | 154.61 on 01/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 35,563 | 76,290,320 | 48,269,404 | 14,188,148 | 11,270,540 |
| Shares Outstanding, K | 31,196 | 447,792 | 3,181,899 | 44,912 | 99,704 |
| Annual Sales | 80,000 | 9,256,000,000 | 29,419,960,000 | 2,877,400,000 | 2,355,300,000 |
| Annual Net Income | -48,820,000 | 2,486,000,000 | 994,060,000 | 1,195,100,000 | 341,300,000 |
| Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 735,900,000 | 627,700,000 |
| Last Quarter Net Income | -11,570,000 | 581,000,000 | 156,180,000 | 301,300,000 | 103,100,000 |
| 60-Month Beta | 0.10 | 0.94 | 0.46 | 0.64 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/14/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | 6.19 on 02/26/25 | 1.00 on 02/06/25 |
| Latest Earnings Date | 04/04/25 | 05/01/25 | 02/06/25 | 02/26/25 | 02/06/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.25 | 10.56 | 12.51 | 34.24 |